ResMed
663 hedge funds and large institutions have $19.2B invested in ResMed in 2021 Q1 according to their latest regulatory filings, with 73 funds opening new positions, 265 increasing their positions, 212 reducing their positions, and 68 closing their positions.
25% more repeat investments, than reductions
Existing positions increased: 265 | Existing positions reduced: 212
7% more first-time investments, than exits
New positions opened: 73 | Existing positions closed: 68
0% more funds holding in top 10
Funds holding in top 10: 8 → 8 (0)
0% less funds holding
Funds holding: 664 → 663 (-1)
8% less call options, than puts
Call options by funds: $23.5M | Put options by funds: $25.4M
1.83% less ownership
Funds ownership: 69.99% → 68.16% (-1.8%)
11% less capital invested
Capital invested by funds: $21.6B → $19.2B (-$2.31B)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OCBV
Ownership Capital B.V.
Amsterdam,
Netherlands
|
+$180M |
| 2 |
Janus Henderson Group
London,
|
+$95.5M |
| 3 |
MWNA
Marshall Wace North America
New York
|
+$37.6M |
| 4 |
D.E. Shaw & Co
New York
|
+$34.9M |
| 5 |
WCM Investment Management
Laguna Beach,
California
|
+$33.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
-$334M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$133M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$103M |
| 4 |
AC
AKO Capital
London,
United Kingdom
|
-$75.7M |
| 5 |
HSBC Holdings
London,
United Kingdom
|
-$63M |
RMD Hedge Fund Activity: Q1 2021 in Review
663 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in ResMed (RMD) for Q1 2021, worth a combined $19.2B — down 11% from $21.6B a quarter earlier.
Buyers outnumbered sellers: 73 funds opened new RMD positions and 68 closed out — a net gain of 5 holders — while 265 added to existing stakes and 212 trimmed.
The largest buyer was Ownership Capital B.V., opening a new position worth an estimated $180M. The largest seller was Capital World Investors, cutting an estimated $334M.
- 663 institutional investors held ResMed (RMD) as of Q1 2021, down from 664 in Q4 2020.
- Funds reported $19.2B of ResMed stock for Q1 2021, down 11% quarter-over-quarter.
- 73 funds opened new ResMed positions in Q1 2021 and 68 closed out, a net change of +5 holders.
- The largest ResMed buyer in Q1 2021 was Ownership Capital B.V., an estimated $180M added.
- The largest ResMed seller in Q1 2021 was Capital World Investors, an estimated $334M sold.
Based on aggregated 13F filings for Q1 2021.